For human neuroblastoma, the amplification of the MYCN(V-myc myelocytomatosis viral-related oncogene, neuroblastoma derived [avian]) oncogene occurs in 20–25% of the patients, and the degree of amplification is associated with advanced stage and poor prognosis27. The gene discussed is MYCN; the disease is neuroblastoma.